Stevens Capital Management LP Astrazeneca PLC Transaction History

Stevens Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$47.16 - $54.44 $339,410 - $391,804	-7,197 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$48.52 - $58.02 $76,127 - $91,033	1,569 Added 27.88%	7,197 $360,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $298,677 - $343,870	5,628 New	5,628 $308,000
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $289,682 - $326,069	-7,859 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $273,178 - $312,159	7,859 New	7,859 $311,000

1,343

492M

4.99M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.